Trials / Unknown
UnknownNCT02963155
Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration
Prospective Study of Natural Killer Cells in Patients With Metastatic Prostate Cancer: Relationship With Survival and Response Time to Castration
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective research of Natural Killer cells as predictive biomarkers to stratify patients likely to have longer response time to castration.
Detailed description
The main objective is to validate prospectively the results of a retrospective study showing a correlation between the level of NKp30 and NKp46 receptor-activators expression on the surface of NK cells and 1) the survival time, 2) the response time to castration in patients with metastatic prostate cancer. Prospective monocenter, open-label study. During a visit in the frame of management of the disease, a single blood sample will be collected. Patients will then have a standard care follow-up for a period of 5 years. Follow up data (death, progression) will be collected every 6 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Blood samples |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-07-07
- Completion
- 2021-11-01
- First posted
- 2016-11-15
- Last updated
- 2020-01-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02963155. Inclusion in this directory is not an endorsement.